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Abstract
Background: EV71 is associated with the fatal cases of brain stem encephalitis during large HFMD outbreaks from 
1998 to 2008. EV71 may continuously shed from upper respiratory tracts and feces of HFMD patients for relatively long 
time after recovery. However, the persistence of viruses in the patients' secretions and excretions is not clear.
Methods: Serial throat swabs and feces of 34 definitely diagnosed patients, including 30 mild cases and 4 severe cases, 
were traced and collected with the interval of 2 to 4 days for up to 32 and 48 days, respectively, and tested by a nested 
RT-PCR.
Results: The EV-71 specific sequences were identified by a Nested RT-PCR in all specimens of 0-4 days, and 5-8 days. 
The positive rates of EV71 in throat swabs dropped markedly to 42.86% during 9-12 days, and maintained at 20-30% 
during 13-24 days, while that in feces reduced to 71.43% during 9-12 days, and maintained roughly 20% till 37-40 days. 
EV71 nucleotide of 36.36% cases disappeared simultaneously both in throats and feces, 39.39% cases showed longer 
persistence of EV71 nucleotides in feces, and 21.21% were longer in throats. The longest duration of shedding 
observed was 24 days for throat swabs and 42 days for fecal specimens.
Conclusions: EV71 shedding from respiratory tract may continue for nearly four weeks after onset, but its excretion 
through feces can persist more than five weeks.
Background
Enterovirus 71 (EV71), which was firstly described in
1969 during an outbreak with central nervous system
complications in California, causes a variety of neurologi-
cal diseases, including aseptic meningitis, encephalitis,
and poliomyelitis-like paralysis [1]. This virus is also one
of only a few enterovirus serotypes most often associated
with large outbreaks of hand, foot, and mouth disease
(HFMD) [2,3]. EV71 is associated with the fatal cases of
brain stem encephalitis during large HFMD outbreaks in
Malaysia (1997) [4], Taiwan (1998, 2000 and 2001) [5-7],
Australia (1999) [8] and Singapore (2000) [8,9]. In March
2008, an EV71 HFMD outbreak appeared in Fuyang City,
Anhui Province of China, and subsequently spread
quickly in almost all provinces in PR China [10].
Continuous circulation of EV71 in the community was
evident, since EV71 has been repeatedly detected and iso-
lated from HFMD outbreaks worldwide every year from
1998 to 2008 [7,9-11]. The transmission pathways of
EV71 are believed to be multiple, i, e, close contact, drop-
lets through respiratory tract and contaminated water
through gastrointestinal tract [12]. HFMD patients and
asymptomatic persons are the major infectious sources.
Some studies have described that EV71 may continuously
shed from upper respiratory tracts and feces of HFMD
patients for relatively long time after recovery [11,13].
However, the persistence of viruses in the patients' secre-
tions and excretions is not well-documented. In this
study, serial throat and feces samples of 34 definitely
diagnosed HFMD cases were collected during and after
hospitalizations, including 30 mild cases and 4 severe
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cases. We found that EV71-related sequences persisted in
the HFMD children for weeks after recovery, although
about half of the cases showed EV71 negative conversion
in the first two weeks after onset.
Methods
Sample collection
34 definitely diagnosed HFMD cases were enrolled in this
study, who had typical clinical manifestations and hospi-
talized. Among them, 30 cases were mild and 4 were
severe. The mean durations in hospital were 5.4 ± 1.2
days in mild group and 5.5 ± 2.4 days in severe one. All
cases were EV71 RNA positive both in respiratory and
feces samples when hospitalized. Medical follow-up and
sampling for each patient was planned to last for 6 weeks
after onset of the disease. Serial throat swabs and feces of
each patient were collected every four days after onset.
All specimens were immediately immersed into sterile
tubes containing viral transport medium. The sample col-
lection started from the beginning of May 2008 and the
last case in this study was enrolled at the end of May .
Total duration of sampling took roughly three months
(from May to July, 2008).
Automated RNA extraction
Prior to RNA extraction, feces samples were treated with
chloroform according to the protocol described else-
where [14]. Automated RNA extractions of all collected
specimens were performed with MagneSil Total RNA
mini-isolation kit (Promega), using the Biomek FX liquid
handler (Beckman Coulter) according to the manufac-
turer's instructions. Briefly, 120 μl throat swabs or pre-
treated feces samples was mixed with 120 μl of lysis
buffer containing carrier RNA and incubated at room
temperature for 10 min. The lysed sample was then trans-
ferred to the 96 wells of a plastic plate with 20 μl of mag-
netic beads, followed by the process of automatic
magnetic separation. RNA was recovered in 40 μl of elu-
tion buffer. The time elapsed from automated RNA
extraction to PCR setting up was less than 35 min. Qual-
ity control did not show any trail of nucleic acids contam-
ination among the samples after extraction by automated
instruments.
Nested RT-PCR for EV71
For amplification of EV71 specific fragment, a Nested
RT-PCR was designed between VP3 to VP1 region of
EV71 with the inner-primer-F (5'-CCATCCAGGGAGA-
TAGGGTAG-3', nt. 2419-2440) and inner-primer-B (5'-
CTGGAACCTTACCTGTGTCCA-3', nt. 2552-2573), as
well as outer-primer-F (5'-GCAGCCCAAAAGAACT-
TCAC-3', nt. 2372-2392) and outer-primer-B (5'-
ATTTCAGCAGCTTGGAGTGC-3', nt. 2578-2598). 11
μl of extracted RNA samples were subjected into the
Nested RT-PCR as described below. Briefly, the reactions
were carried out with One-Step RT-PCR kit (QIAGEN)
on 7500 fast PCR instrument (Applied Biosystems), with
an initial reverse transcription step at 42°C for 45 min,
followed by PCR activation at 95°C for 10 min and 35
cycles of amplification (94°C for 30 s, 45°C for 30 s, 72°C
for 30 s). Nested PCR assays were subsequently per-
formed with 1:10 dilution of previous RT-PCR products
on 7500 fast PCR instrument (Applied Biosystems), pro-
grammed with the following parameters (32 cycles of
94°C for 30 s, 45°C for 30 s and 72°C for 30 s). PCR prod-
ucts were observed in 2% agarose electrophoresis.
Statistical analysis
The differences of the persistence of EV71 nucleotides
between mild and severe cases, between genders and
among the onset ages were performed with Chi-Square
tests.
Ethical approval
This study was approved by the Ethical Committee of
National Institute for Viral Disease Control and Preven-
tion, China CDC. Sample collection was agreed by child's
parents or grandparents with informed consent.
Results
A nested RT-PCR protocol for EV71 sequences had been
set up, producing a 226 bp and a 154 bp product in the
first and second PCR reaction, respectively. The sensitiv-
ity of this method for EV71 had been previously mea-
sured, which was able to detect 102 and 101 copies of virus
based on PFU test. The specificity of this assay was tested
with the RNAs extracted from other enteroviruses,
including CA16, CA24, CB2-5, ECV9 and ECV30. No
cross-amplification was obtained.
A total of 34 definitely diagnosed HFMD cases were
subjected into this study. All cases had serial feces sam-
ples and 33 cases had serial throat swabs. The average
ages were 2.3 ± 1.6 years old and gender ratio was 22:12.
Mostly the first samples of the cases (31/34) were col-
lected during the first week after onset based on the time
of hospitalization. RT-PCR tests revealed that the first
respiratory and feces samples of all cases were EV71 posi-
tive. The throat swabs and feces of these patients were
traced and collected with the interval of 2 to 4 days and
grouped each four days after onset. Each case contained
at least five serial samples after the first one. The longest
time of the collected throat swabs and feces were 32 and
48 days after onset, respectively.
Based on the grouping, each group had about twenty
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ing 9-12 days, and maintained at about 20-30% during 13
to 24 days after onset, while that in feces reduced to
71.43% during 9-12 days, and maintained roughly 20%
afterwards till 37-40 days after onset. EV71 associated
nucleotides were undetectable in respiratory samples
fourth weeks after onset and almost undetectable in feces
more than five weeks later. The longest EV71-postive
time in throat swab was 24 days and that in feces was 42
days post-onset.
To evaluate the negative conversion rate in clinical sam-
ples of EV71 nucleotides after disease, the time period of
EV71 negative closest to that of EV71 positive was taken
as the time of EV71 nucleotide negative conversion. Fig-
ure 2 showed that none of the tested cases converted to
EV71 negative in throats or in feces in the first four days.
In the time period of 5-8 days, only one feces showed
EV71 negative conversion. EV71 negative conversion
happened mostly in the time periods of 9-12 days and 13-
16 days after onset. 48.48% throat swabs and 17.65% feces
samples in the period of 9-12 days, as well as 12.12%
throat swabs and 38.24% feces samples in the period of
13-16 days were EV71 negative, respectively. Afterwards,
the EV71 negative conversion rates increased gradually in
throats and feces, but EV71 nucleotides in feces samples
lasted clearly longer than that in throats. No significant
difference in persistence of EV71 nucleotides were ana-
lyzed between mild and severe cases, between genders
and among the onset ages.
To figure out the possible different profiles of EV71 dis-
appearance, persistent states of EV71 nucleotides in
throats compared to feces of individual patient were ana-
lyzed. 36.36% (12/33) cases revealed almost same time
period of EV71 nucleotide disappearance both in throats
and feces, 39.39% (13/33) cases showed longer persis-
tence of EV71 nucleotides in feces, and 21.21% (7/33)
were longer in throats (Figure 3). Furthermore, the identi-
fications of EV71 nucleotides in each time period of indi-
vidual case were counted. Only two out thirty-three cases
showed EV71 positive in the subsequent samples after
previous negative in their serial throat samples, however,
6 cases were EV71 positive reversion in the serial feces
samples.
Discussion
HFMD has been an important public health concern
worldwide, especially in the Asia-Pacific region. Up to
now, more than 900,000 HFMD cases have been reported
in mainland of China. Enteroviruses can be isolated from
both the lower and upper alimentary tract and can be
transmitted by both fecal-oral and respiratory routes.
Fecal-oral transmission may predominate in areas with
Figure 1 The positive rates of EV71 nucleotides in samples from 
the definitely diagnosed HFMD patients. The positive rates of EV71 
related nucleosides identified in serially collected throats and feces 
samples from the definitely diagnosed HFMD patients. Square hole 
represents RT-PCR positive rates from feces sample. Black square rep-
resents RT-PCR positive rates from throat swabs.
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Figure 2 The portions of negative conversion of EV71 nucleo-
sides in the HFMD convalescent. The portions of negative conver-
sion of EV71 related nucleosides in throats and feces samples from the 
HFMD patients in the convalescent.
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Figure 3 Comparison of the clearances of EV71 in the throat and 
feces specimen of individual cases. F: feces; T: throat. The right Y-axis 
represents the numbers of the cases and the left Y-axis represent the 
percentages.
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poor sanitary conditions, whereas respiratory transmis-
sion may be important in more developed areas. The rel-
ative importance of the different modes of transmission
probably varies with the particular EV and environmental
setting [1]. Like other infections of enteroviruses, e.g.
Coxsackie's viruses and polioviruses, EV71-caused
HFMD often occurred sporadically or epidemically,
sometimes without clear transmission chain [2,15]. One
of the reasons is believed to be the wide and continuous
circulation of EV71 among humans as well as environ-
ment [16,17]. On the other hand, long time of virus per-
sistence and shedding in the patients' secretions and
excretions makes infectious sources be more abundant.
Additionally, relatively stronger resistance of viruses in
environment let the disease more easily transmit [18].
With the established nested RT-PCR, we prove a long
persistence of EV71 nucleotides in the throats and feces
of the patients with HFMD. Only about half of the
patients show EV71 negative in their respiratory secre-
tions and stools two weeks after onset. The traditional
techniques for detecting and characterizing enteroviruses
rely on the time-consuming and labor-intensive proce-
dures of viral isolation in cell culture and neutralization
by reference antisera [1,19]. Virus persistent time in the
throat in this study seems to be longer than that of previ-
ous data, mostly obtained from virus culture, which
showed EV71 shedding up to 2 weeks [13]. Isolation of
enteroviruses from specimens need appropriate cultured
cell lines and suitable specimen. The best specimens for
isolation of virus are, in order of preference, stool speci-
mens or rectal swabs, throat swabs or washings, and cere-
brospinal fluid. Throat swabs or washings and CSF are
most likely to yield virus isolates if they are obtained early
in the acute phase of the illness [19,20]. Overall, the posi-
tive rate of virus isolation for enteroviruses from throat
swabs in acute period is less than 50%. Even combined
throat plus vesicle swabs enables the identification of
virus increase, but still less than 70% [9,13]. It is obvious
that measurement of EV71 shedding merely based on
virus culture will result in a portion of false negative. Cer-
tainly, identification of positive EV71 nucleotides by PCR
in specimen does not indicate the presence of 100% live
virus. Therefore, combination of the results from those
two techniques may be more helpful for evaluating EV71
shedding. Additionally, detection of virus in a sample
does not equal to being able to set up an efficient infec-
tion or transmission, which may be influenced by numer-
ous factors, e.g virus load, exposing time and pathway,
environmental and host situations.
In line with the concept that the EV shedding time from
gastrointestinal tract usually longer than from respiratory
tract [13], our study also illustrates a similar pattern that
more than 20% cases maintain EV71 positive in the stool
samples after clearance of EV71 nucleotides in their
throats. It highlights a special requirement of decontami-
nation for feces after recovery.
Conclusions
Excretion of EV71 may persist for months after infection,
but most cases become negative 2 weeks after onset.
Thus, the patients during the first 2 weeks should be at
high risk to spread the pathogens.
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